CSF insulin-like growth factor-1 in infantile neuronal ceroid lipofuscinosis

被引:34
作者
Riikonen, R
Vanhanen, SL
Tyynelä, J
Santavuori, P
Turpeinen, U
机构
[1] Kuopio Univ Hosp, Kuopio, Finland
[2] Hosp Children & Adolescents, Helsinki, Finland
[3] Univ Helsinki, Inst Biomed, FIN-00014 Helsinki, Finland
[4] Univ Helsinki, Cent Hosp Lab, FIN-00014 Helsinki, Finland
关键词
CSF insulin-like growth factor-1; infantile neuronal ceroid lipofuscinosis; apoptosis;
D O I
10.1212/WNL.54.9.1828
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Infantile neuronal ceroid lipofuscinosis (INCL) is a progressive encephalopathy in which the patients are severely disabled by the age of 3 years. It is characterized by cerebral atrophy, selective loss of cortical neurons, and secondary loss of axons and myelin sheaths of the white matter. INCL has been shown to result from a palmitoyl protein thioesterase deficiency. The authors suggested that insulin-like growth hormones and apoptosis might play a role in the pathogenesis of INCL. Methods: The authors measured insulin-like growth factor-1 (IGF-1) and IGF binding protein 3 (IGFBP-3) in the CSF of patients with INCL by radioimmunoassay at an early stage when myelin was starting to diminish. Results: The authors found low CSF IGF-1 but normal IGFBP-3 in patients with INCL compared with control subjects. Also, they observed apoptotic cell death in biopsies of INCL patients. Conclusions: Because the IGF system seems to be important for early brain development, myelination, and neuroprotection, the authors suggest that the pathology in INCL may be associated with low CSF IGF-1.
引用
收藏
页码:1828 / 1832
页数:5
相关论文
共 42 条
[21]   INFANTILE FORM OF NEURONAL CEROID LIPOFUSCINOSIS (CLN1) MAPS TO THE SHORT ARM OF CHROMOSOME-1 [J].
JARVELA, I ;
SCHLEUTKER, J ;
HAATAJA, L ;
SANTAVUORI, P ;
PUHAKKA, L ;
MANNINEN, T ;
PALOTIE, A ;
SANDKUIJL, LA ;
RENLUND, M ;
WHITE, R ;
AULA, P ;
PELTONEN, L .
GENOMICS, 1991, 9 (01) :170-173
[22]   Leukocytes in neuronal ceroid-lipofuscinoses: Function and apoptosis [J].
Kieseier, BC ;
Wisniewski, KE ;
Park, E ;
SchullerLevis, G ;
Mehta, PD ;
Goebel, HH .
BRAIN & DEVELOPMENT, 1997, 19 (05) :317-322
[23]   WALLERIAN DEGENERATION - EVALUATION WITH MR IMAGING [J].
KUHN, MJ ;
JOHNSON, KA ;
DAVIS, KR .
RADIOLOGY, 1988, 168 (01) :199-202
[24]   Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I [J].
Kulik, G ;
Weber, MJ .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (11) :6711-6718
[25]  
Lane SC, 1996, J NEUROCHEM, V67, P677
[26]   INSULIN-LIKE GROWTH FACTOR-I STIMULATES OLIGODENDROCYTE DEVELOPMENT AND MYELINATION IN RAT-BRAIN AGGREGATE CULTURES [J].
MOZELL, RL ;
MCMORRIS, FA .
JOURNAL OF NEUROSCIENCE RESEARCH, 1991, 30 (02) :382-390
[27]   CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide [J].
Puranam, KL ;
Guo, WX ;
Qian, WH ;
Nikbakht, K ;
Boustany, RM .
MOLECULAR GENETICS AND METABOLISM, 1999, 66 (04) :294-308
[28]   Low insulin-like growth factor (IGF-1) in the cerebrospinal fluid of children with progressive encephalopathy, hypsarrhythmia, and optic atrophy (PEHO) syndrome and cerebellar degeneration [J].
Riikonen, R ;
Somer, M ;
Turpeinen, U .
EPILEPSIA, 1999, 40 (11) :1642-1648
[29]   INFANTILE TYPE OF SO-CALLED NEURONAL CEROID-LIPOFUSCINOSIS .1. CLINICAL STUDY OF 15 PATIENTS [J].
SANTAVUORI, P ;
HALTIA, M ;
RAPOLA, J ;
RAITTA, C .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1973, 18 (03) :257-267
[30]  
Santavuori P, 1999, BIOM HLTH R, V33, P16